Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions

References

• Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med. 2004;25(4):249–256.
   PubMed Web of Science ®Google Scholar
• Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med. 2008;29(1):28–44.
   PubMed Web of Science ®Google Scholar
• Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210.
   PubMed Web of Science ®Google Scholar
• Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11–29.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Sharma M, Gibson RN, et al. Fortuitously discovered liver lesions. World J Gastroenterol. 2013;19(21):3173–3188.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Kratzer W, Strobe D, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol. 2006;12(11):1699–1705.
   PubMed Web of Science ®Google Scholar
• Chiorean L, Cantisani V, Jenssen C, et al. Focal masses in a non-cirrhotic liver: the additional benefit of CEUS over baseline imaging. Eur J Radiol. 2015;84(9):1636–1643.
   PubMed Web of Science ®Google Scholar
• Chiorean L, Caraiani C, Radzina M, et al. Vascular phases in imaging and their role in focal liver lesions assessment. Clin Hemorheol Microcirc. 2015;62(4):299–326.
   PubMed Web of Science ®Google Scholar
• Seitz K, Strobel D, Bernatik T, et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall Med. 2009;30(4):383–389.
   PubMed Web of Science ®Google Scholar
• Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med. 2008;29(5):499–505.
   PubMed Web of Science ®Google Scholar
• Piscaglia F, Tewelde AG, Righini R, et al. Knowledge of the bio-effects of ultrasound among physicians performing clinical ultrasonography: results of a survey conducted by the Italian Society for Ultrasound in Medicine and Biology (SIUMB). J Ultrasound. 2009;12(1):6–11.
   PubMedGoogle Scholar
• Schreiber-Dietrich DG, Cui XW, Piscaglia F, et al. Contrast enhanced ultrasound in pediatric patients: a real challenge. Z Gastroenterol. 2014;52(10):1178–1184.
   PubMed Web of Science ®Google Scholar
• Sidhu PS, Cantisani V, Deganello A, et al. Role of Contrast-Enhanced Ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med. 2017;38(1):33–43.
   PubMed Web of Science ®Google Scholar
• Dietrich CF. EFSUMB guidelines 2015 on interventional ultrasound. Med Ultrason. 2015;17(4):521–527.
   PubMed Web of Science ®Google Scholar
• Sidhu PS, Brabrand K, Cantisani V, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part II. Diagnostic ultrasound-guided interventional procedures (long version). Ultraschall Med. 2015;36(6):E15–35.
   PubMed Web of Science ®Google Scholar
• Sidhu PS, Brabrand K, Cantisani V, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part II. Diagnostic ultrasound-guided interventional procedures (short version). Ultraschall Med. 2015;36(6):566–580.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Lorentzen T, Appelbaum L, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part III - abdominal treatment procedures (long version). Ultraschall Med. 2016;37(1):E1–E32.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Lorentzen T, Appelbaum L, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part III - abdominal treatment procedures (short version). Ultraschall Med. 2016;37(1):27–45.
   PubMed Web of Science ®Google Scholar
• Tang A, Bashir MR, Corwin MT, et al. Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review. Radiology. 2018;286(1):29–48.
   PubMed Web of Science ®Google Scholar
• Wilson SR, Lyshchik A, Piscaglia F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY). 2018;43(1):127–142.
   PubMed Web of Science ®Google Scholar
• Lyshchik A, Kono Y, Dietrich CF, et al. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY). 2018;43(4):861-879.
   Web of Science ®Google Scholar
• Kim TK, Noh SY, Wilson SR, et al. Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system. Clin Mol Hepatol. 2017;23(4):280–289.
   PubMed Web of Science ®Google Scholar
• Piscaglia F, Wilson SR, Lyshchik A, et al. American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall Med. 2017;38(3):320–324.
   PubMed Web of Science ®Google Scholar
• Kono Y, Lyshchik A, Cosgrove D, et al. Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS(R)): the official version by the American College of Radiology (ACR). Ultraschall Med. 2017;38(1):85–86.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Averkiou M, Nielsen MB, et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound Int Open. 2018;4(1):E2–E15.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Averkiou MA, Correas JM, et al. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012;33(4):344–351.
   PubMed Web of Science ®Google Scholar
• Frohlich E, Muller R, Cui XW, et al. Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion. J Ultrasound Med. 2015;34(2):179–196.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Dong Y, Froehlich E, et al. Dynamic contrast-enhanced endoscopic ultrasound: a quantification method. Endosc Ultrasound. 2017;6(1):12–20.
   PubMed Web of Science ®Google Scholar
• Chiorean L, Tana C, Braden B, et al. Advantages and limitations of focal liver lesion assessment with ultrasound contrast agents: comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines. Med Princ Pract. 2016;25(5):399–407.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Horn R, Morf S, et al. US-guided peripheral vascular interventions, comments on the EFSUMB guidelines. Med Ultrason. 2016;18(2):231–239.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Horn R, Morf S, et al. Ultrasound-guided central vascular interventions, comments on the European Federation of Societies for Ultrasound in Medicine and Biology guidelines on interventional ultrasound. J Thorac Dis. 2016;8(9):E851–E868.
   PubMed Web of Science ®Google Scholar
• Lorentzen T, Nolsoe CP, Ewertsen C, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part I. general aspects (long version). Ultraschall Med. 2015;36(5):E1–14.
   PubMed Web of Science ®Google Scholar
• Lorentzen T, Nolsoe CP, Ewertsen C, et al. EFSUMB guidelines on interventional ultrasound (INVUS), part I. general aspects (short version). Ultraschall Med. 2015;36(5):464–472.
   PubMed Web of Science ®Google Scholar
• Mohaupt MG, Arampatzis S, Atkinson N, et al. Comments and extensions to EFSUMB guidelines on renal interventional ultrasound (INVUS). Med Ultrason. 2016;18(3):351–361.
   PubMed Web of Science ®Google Scholar
• Piscaglia F, Bolondi L. Italian Society for Ultrasound in M, Biology study group on ultrasound contrast A. The safety of sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32(9):1369–1375.
   PubMed Web of Science ®Google Scholar
• Smajerova M, Petrasova H, Little J, et al. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: a cost-effectiveness analysis. World J Gastroenterol. 2016;22(38):8605–8614.
   PubMed Web of Science ®Google Scholar
• Schuler A, Reuss J, Delorme S, et al. [Costs of clinical ultrasound examinations - an economical cost calculation and analysis]. Ultraschall Med. 2010;31(4):379–386.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Ignee A, Trojan J, et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut. 2004;53(3):401–405.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Schuessler G, Trojan J, et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol. 2005;78(932):704–707.
   PubMed Web of Science ®Google Scholar
• Strobel D, Seitz K, Blank W, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med. 2009;30(4):376–382.
   PubMed Web of Science ®Google Scholar
• Seitz K, Greis C, Schuler A, et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med. 2011;32(6):598–603.
   PubMed Web of Science ®Google Scholar
• Strobel D, Bernatik T, Blank W, et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (</= 20 mm) and subcentimetric (</= 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med. 2011;32(6):593–597.
   PubMed Web of Science ®Google Scholar
• Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol. 2009;15(30):3748–3756.
   PubMed Web of Science ®Google Scholar
• Cantisani V, David E, Meloni FM, et al. Recall strategies for patients found to have a nodule in cirrhosis: is there still a role for CEUS? Med Ultrason. 2015;17(4):515–520.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Mertens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology. 2007;45(5):1139–1145.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Maddalena ME, Cui XW, et al. Liver tumor characterization–review of the literature. Ultraschall Med. 2012;33(Suppl 1):S3–10.
   PubMedGoogle Scholar
• Trojan J, Hammerstingl R, Engels K, et al. Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors. J Clin Ultrasound. 2010;38(5):227–231.
   PubMed Web of Science ®Google Scholar
• Dong Y, Wang WP, Cantisani V, et al. Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol. 2016;22(19):4741–4749.
   PubMed Web of Science ®Google Scholar
• Blondet A, Ridereau-Zins C, Michalak S, et al. [Multiple pedunculated liver hemangiomas presenting with volvulus]. J Radiol. 2007;88(6):891–894.
   PubMedGoogle Scholar
• Caseiro-Alves F, Brito J, Araujo AE, et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol. 2007;17(6):1544–1554.
   PubMed Web of Science ®Google Scholar
• Caraiani C, Chiorean L, Fenesan DI, et al. Diffusion weighted magnetic resonance imaging for the classification of focal liver lesions as benign or malignant. J Gastrointestin Liver Dis. 2015;24(3):309–317.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Ignee A, Hocke M, et al. Pitfalls and artefacts using contrast enhanced ultrasound. Z.Gastroenterol. 2011;49(3):350–356.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Ignee A, Greis C, et al. Artifacts and pitfalls in contrast-enhanced ultrasound of the liver. Ultraschall Med. 2014;35(2): 108–125. quiz 126–107.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Greis C. [How to perform contrast enhanced ultrasound]. Dtsch Med Wochenschr. 2016;141(14):1019–1024.
   PubMed Web of Science ®Google Scholar
• Ignee A, Piscaglia F, Ott M, et al. A benign tumour of the liver mimicking malignant liver disease–cholangiocellular adenoma. Scand J Gastroenterol. 2009;44(5):633–636.
   PubMed Web of Science ®Google Scholar
• Campos JT, Sirlin CB, Choi JY. Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas. Insights Imaging. 2012;3(5):451–474.
   PubMedGoogle Scholar
• Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology. 2001;221(3):731–739.
   PubMed Web of Science ®Google Scholar
• Grazioli L, Federle MP, Brancatelli G, et al. Hepatic adenomas: imaging and pathologic findings. Radiographics. 2001;21(4): 877–892. discussion 892–874.
   PubMed Web of Science ®Google Scholar
• Bieze M, Van Den Esschert JW, Nio CY, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199(1):26–34.
   PubMed Web of Science ®Google Scholar
• Hirche TO, Ignee A, Hirche H, et al. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int. 2007;27(6):748–757.
   PubMed Web of Science ®Google Scholar
• Schuessler G, Ignee A, Hirche T, et al. [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound]. Z.Gastroenterol. 2003;41(12):1167–1176.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Wehrmann T, Zeuzem S, et al. [Analysis of hepatic echo patterns in chronic hepatitis C]. Ultraschall Med. 1999;20(1):9–14.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Jenssen C. [Focal liver lesion, incidental finding]. Dtsch Med Wochenschr. 2012;137(41):2099–2116.
   PubMed Web of Science ®Google Scholar
• Dietrich CF. Comments and illustrations regarding the guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS)–update 2008. Ultraschall Med. 2008;29(Suppl 4):S188–S202.
   PubMedGoogle Scholar
• Dietrich CF. Liver tumor characterization–comments and illustrations regarding guidelines. Ultraschall Med. 2012;33(Suppl 1):S22–30.
   PubMedGoogle Scholar
• Dietrich CF, Cui XW, Schreiber-Dietrich DG, et al. EFSUMB guidelines 2011: comments and illustrations. Ultraschall Med. 2012;33(Suppl 1):S11–21.
   PubMedGoogle Scholar
• Schreiber-Dietrich D, Chiorean L, Cui XW, et al. Particularities of Crohn’s disease in pediatric patients: current status and perspectives regarding imaging modalities. Expert Rev Gastroenterol Hepatol. 2015;9(10):1313–1325.
   PubMed Web of Science ®Google Scholar
• Barreiros AP, Otto G, Ignee A, et al. Sonographic signs of amyloidosis. Z.Gastroenterol. 2009;47(8):731–739.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Brunner V, Lembcke B. [Intestinal ultrasound in rare small and large intestinal diseases]. Z.Gastroenterol. 1998;36(11):955–970.
   PubMed Web of Science ®Google Scholar
• Barreiros AP, Chiorean L, Braden B, et al. Ultrasound in rare diffuse liver disease. Z Gastroenterol. 2014;52(11):1247–1256.
   PubMed Web of Science ®Google Scholar
• Dong Y, Wang WP, Mao F, et al. Contrast enhanced ultrasound features of hepatic cystadenoma and hepatic cystadenocarcinoma. Scand J Gastroenterol. 2017;52(3):365–372.
   PubMed Web of Science ®Google Scholar
• Schuessler G, Fellbaum C, Fauth F, et al. [The infammatory pseudotumour – an unusual liver tumour]. Ultraschall Med. 2006;27(3):273–279.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Sharma M, Chaubal N, et al. Ascariasis imaging: pictorial essay. Z Gastroenterol. 2017;55(5):479–489.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Kabaalioglu A, Brunetti E, et al. Fasciolosis. Z Gastroenterol. 2015;53(4):285–290.
   PubMed Web of Science ®Google Scholar
• Barreiros AP, Braden B, Schieferstein-Knauer C, et al. Characteristics of intestinal tuberculosis in ultrasonographic techniques. Scand J Gastroenterol. 2008;43(10):1224–1231.
   PubMed Web of Science ®Google Scholar
• Dietrich CF. Significance of abdominal ultrasound in inflammatory bowel disease. Dig Dis. 2009;27(4):482–493.
   PubMed Web of Science ®Google Scholar
• Dong Y, Jurgensen C, Puri R, et al. Ultrasound imaging features of isolated pancreatic tuberculosis. Endosc Ultrasound. 2018;7(2):119-127.
   Google Scholar
• Tana C, Dietrich CF, Schiavone C. Hepatosplenic sarcoidosis: contrast-enhanced ultrasound findings and implications for clinical practice. Biomed Res Int. 2014;926203:2014.
   Google Scholar
• Tana C, Silingardi M, Dietrich CF. New trends in ultrasound of hepatosplenic sarcoidosis. Z Gastroenterol. 2015;53(4):283–284.
   PubMed Web of Science ®Google Scholar
• Wang B, Ye Z, Chen Y, et al. Hepatic angiomyolipomas: ultrasonic characteristics of 25 patients from a single center. Ultrasound Med Biol. 2015;41(2):393–400.
   PubMed Web of Science ®Google Scholar
• Chiorean L, Cui XW, Tannapfel A, et al. Benign liver tumors in pediatric patients - Review with emphasis on imaging features. World J Gastroenterol. 2015;21(28):8541–8561.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Mueller G, Beyer-Enke S. Cysts in the cyst pattern. Z.Gastroenterol. 2009;47(12):1203–1207.
   PubMed Web of Science ®Google Scholar
• Braden B, Helm B, Fabian T, et al. [Bacillary angiomatosis of the liver, a suspected ultrasound diagnosis?]. Z.Gastroenterol. 2000;38(9):785–789.
   PubMedGoogle Scholar
• Tana C, Dietrich CF, Badea R, et al. Contrast-enhanced ultrasound in portal venous system aneurysms: a multi-center study. World J Gastroenterol. 2014;20(48):18375–18383.
   PubMed Web of Science ®Google Scholar
• Schreiber-Dietrich DG, Leuschner I, Tannapfel A, et al. [Primary liver tumours in childhood]. Z Gastroenterol. 2015;53(11):1267–1275.
   PubMed Web of Science ®Google Scholar
• Wilson SR, Lyshchik A, Piscaglia F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY). 2018;43(1):127-142.
   Web of Science ®Google Scholar
• Kim TK, Noh SY, Wilson SR, et al. Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system. Clin Mol Hepatol. 2017.
   Web of Science ®Google Scholar
• Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol. 2012;57(4):930–932.
   PubMed Web of Science ®Google Scholar
• Tana C, Tana M, Rossi S, et al. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. J Ultrasound. 2016;19(3):183–189.
   PubMed Web of Science ®Google Scholar
• Tana C, Iannetti G, D’Alessandro P, et al. Pitfalls of contrast-enhanced ultrasound (CEUS) in the diagnosis of splenic sarcoidosis. J Ultrasound. 2013;16(2):75–80.
   PubMedGoogle Scholar
• Chokoeva AA, Tchernev G, Tana M, et al. Exclusion criteria for sarcoidosis: a novel approach for an ancient disease? Eur J Intern Med. 2014;25(10):e120.
   PubMed Web of Science ®Google Scholar
• Chokoeva AA, Tchernev G, Tana C, et al. Sarcoid-like pattern in a patient with tuberculosis. J Biol Regul Homeost Agents. 2014;28(4):783–788.
   PubMed Web of Science ®Google Scholar
• Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol. 2004;51(Suppl):S9–17.
   PubMedGoogle Scholar
• Frohlich E, Jenssen C, Schuler A, et al. [Contrast-enhanced ultrasound for characterisation of focal liver lesions, practical advice]. Z Gastroenterol. 2015;53(9):1099–1107.
   PubMed Web of Science ®Google Scholar
• Cui XW, Ignee A, Hocke M, et al. Prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound. Ultraschall Med. 2014;35(3):246–252.
   PubMed Web of Science ®Google Scholar
• Tana C, Iannetti G, Mezzetti A, et al. Heterogeneous delayed enhancement of the liver after administration of ultrasound contrast agents: are we sure that it is a harmless phenomenon? Ultrasound Med Biol. 2013;39(11):2214.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 2017;38(4):e16–e47.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (short version). Ultraschall Med. 2017;38(4):377–394.
   PubMed Web of Science ®Google Scholar
• Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (short version). Ultraschall Med. 2018;39(2):154-180.
   Web of Science ®Google Scholar
• Dietrich CF, Goudie A, Chiorean L, et al. Point of care ultrasound: a WFUMB position paper. Ultrasound Med Biol. 2017;43(1):49–58.
   PubMed Web of Science ®Google Scholar